{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T06:54:30Z","timestamp":1663311270571},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med.","J. Jpn. Soc. Intern. Med"],"published-print":{"date-parts":[[2011]]},"DOI":"10.2169\/naika.100.1875","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T23:10:31Z","timestamp":1365549031000},"page":"1875-1884","source":"Crossref","is-referenced-by-count":1,"title":["4. Role of Hematopoietic Stem Cell Transplantation in the Treatment of Lymphoid Malignancies."],"prefix":"10.2169","volume":"100","author":[{"given":"Yoshinobu","family":"Kanda","sequence":"first","affiliation":[{"name":"Division of Hematology, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Yanada M, et al: Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis. Cancer 103: 1652-1658, 2005.","DOI":"10.1002\/cncr.20945"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kako S, et al: A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor. Leukemia 25: 259-265, 2011.","DOI":"10.1038\/leu.2010.260"},{"key":"3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Oliansky DM, et al: The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review. Biol Blood Marrow Transplant 17: 20-47 e30.","DOI":"10.1016\/j.bbmt.2010.07.008"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Philip T, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333: 1540-1545, 1995.","DOI":"10.1056\/NEJM199512073332305"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Linch DC, et al: Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 341: 1051-1054, 1993.","DOI":"10.1016\/0140-6736(93)92411-L"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Schmitz N, et al: Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet 359: 2065-2071, 2002.","DOI":"10.1016\/S0140-6736(02)08938-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Koreth J, et al: High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. Biol Blood Marrow Transplant 13: 183-196, 2007.","DOI":"10.1016\/j.bbmt.2006.09.010"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Attal M, et al: Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 349: 2495-2502, 2003.","DOI":"10.1056\/NEJMoa032290"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Spencer A, et al: Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure. J Clin Oncol 27: 1788-1793, 2009.","DOI":"10.1200\/JCO.2008.18.8573"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Facon T, et al: Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial. Lancet 370: 1209-1218, 2007.","DOI":"10.1016\/S0140-6736(07)61537-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Bruno B, et al: A comparison of allografting with autografting for newly diagnosed myeloma. N Engl J Med 356: 1110-1120, 2007.","DOI":"10.1056\/NEJMoa065464"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/100\/7\/100_1875\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T16:53:32Z","timestamp":1621443212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/100\/7\/100_1875\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.100.1875","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}